Prospective of 68Ga-radiopharmaceutical development

I Velikyan - Theranostics, 2013 - pmc.ncbi.nlm.nih.gov
Positron Emission Tomography (PET) experienced accelerated development and has
become an established method for medical research and clinical routine diagnostics on …

Bifunctional gallium-68 chelators: Past, present, and future

P Spang, C Herrmann, F Roesch - Seminars in nuclear medicine, 2016 - Elsevier
This article reviews the development of bifunctional chelates for synthesising 68 Ga
radiopharmaceuticals. It structures the chelates into groups of macrocycles …

Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography

MD Bartholomä - Inorganica Chimica Acta, 2012 - Elsevier
In recent years, Positron Emission Tomography (PET) has become a practical, high
performance clinical imaging modality for visualization of biological process within the living …

Optimization of Artificial Siderophores as 68Ga-Complexed PET Tracers for In Vivo Imaging of Bacterial Infections

C Peukert, LNB Langer, SM Wegener… - Journal of Medicinal …, 2021 - ACS Publications
The diagnosis of bacterial infections at deep body sites benefits from noninvasive imaging of
molecular probes that can be traced by positron emission tomography (PET). We specifically …

Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of 68 Ga-TRAP (RGD) 3

J Notni, K Pohle, HJ Wester - Nuclear medicine and biology, 2013 - Elsevier
Gallium-68 is rapidly gaining importance, as this generator-produced PET isotope is
available independent of on-site cyclotrons, enabling radiopharmaceutical production with …

There is a world beyond αvβ3-integrin: multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography

K Steiger, NG Quigley, T Groll, F Richter, MA Zierke… - EJNMMI research, 2021 - Springer
Background In the context of nuclear medicine and theranostics, integrin-related research
and development was, for most of the time, focused predominantly on'RGD peptides' and the …

In vivo PET imaging of the cancer integrin αvβ6 using 68Ga-labeled cyclic RGD nonapeptides

J Notni, D Reich, OV Maltsev, TG Kapp… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Expression of the cellular transmembrane receptor αvβ6 integrin is essentially restricted to
malignant epithelial cells in carcinomas of a broad variety of lineages, whereas it is virtually …

Design of a small-molecule drug conjugate for prostate cancer targeted theranostics

A Kumar, T Mastren, B Wang, JT Hsieh… - Bioconjugate …, 2016 - ACS Publications
Targeted therapy has become an effective strategy of precision medicine for cancer
treatment. Based on the success of antibody-drug conjugates (ADCs), here we report a …

RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga

E Boros, CL Ferreira, DTT Yapp, RK Gill… - Nuclear medicine and …, 2012 - Elsevier
INTRODUCTION: The rekindled interest in the 68Ga generator as an attractive positron
emission tomography generator system has led us and others to investigate novel chelate …

PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with 68Ga-Labeled Benzenesulfonamides

J Lau, Z Zhang, S Jenni, HT Kuo, Z Liu… - Molecular …, 2016 - ACS Publications
Carbonic anhydrase IX (CA-IX) is a HIF-1-inducible enzyme that is overexpressed in many
cancer subtypes to promote survival and invasion in hypoxic niches. Pharmacologic …